Ryan KB[au] - Search Results

Year	Number of Results
1985	1
1997	1
2001	1
2003	1
2011	1
2012	2
2013	2
2015	1
2016	1
2017	2
2020	2
2021	2
2022	4
2023	1

1

Strategies to Mitigate and Treat Orthopaedic Device-Associated Infections.

Kennedy DG, O'Mahony AM, Culligan EP, O'Driscoll CM, Ryan KB. Kennedy DG, et al. Among authors: ryan kb. Antibiotics (Basel). 2022 Dec 15;11(12):1822. doi: 10.3390/antibiotics11121822. Antibiotics (Basel). 2022. PMID: 36551479 Free PMC article. Review.

2

Sphingosine 1-phosphate, a potential target in neovascular retinal disease.

Alshaikh RA, Ryan KB, Waeber C. Alshaikh RA, et al. Among authors: ryan kb. Br J Ophthalmol. 2022 Sep;106(9):1187-1195. doi: 10.1136/bjophthalmol-2021-319115. Epub 2021 May 7. Br J Ophthalmol. 2022. PMID: 33962970 Review.

3

Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies.

Alshaikh RA, Waeber C, Ryan KB. Alshaikh RA, et al. Among authors: ryan kb. Adv Drug Deliv Rev. 2022 Aug;187:114342. doi: 10.1016/j.addr.2022.114342. Epub 2022 May 13. Adv Drug Deliv Rev. 2022. PMID: 35569559 Free article. Review.

4

Mesoporous silica formulation strategies for drug dissolution enhancement: a review.

McCarthy CA, Ahern RJ, Dontireddy R, Ryan KB, Crean AM. McCarthy CA, et al. Among authors: ryan kb. Expert Opin Drug Deliv. 2016;13(1):93-108. doi: 10.1517/17425247.2016.1100165. Epub 2015 Nov 7. Expert Opin Drug Deliv. 2016. PMID: 26549623 Review.

5

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Galvin P, Thompson D, Ryan KB, McCarthy A, Moore AC, Burke CS, Dyson M, Maccraith BD, Gun'ko YK, Byrne MT, Volkov Y, Keely C, Keehan E, Howe M, Duffy C, MacLoughlin R. Galvin P, et al. Among authors: ryan kb. Cell Mol Life Sci. 2012 Feb;69(3):389-404. doi: 10.1007/s00018-011-0856-6. Epub 2011 Oct 21. Cell Mol Life Sci. 2012. PMID: 22015612 Review.

6

Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Sartawi Z, Schipani E, Ryan KB, Waeber C. Sartawi Z, et al. Among authors: ryan kb. Pharmacol Res. 2017 Nov;125(Pt B):232-245. doi: 10.1016/j.phrs.2017.08.013. Epub 2017 Sep 22. Pharmacol Res. 2017. PMID: 28855094 Free PMC article. Review.

7

Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern.

Dozzo A, Galvin A, Shin JW, Scalia S, O'Driscoll CM, Ryan KB. Dozzo A, et al. Among authors: ryan kb. Drug Deliv Transl Res. 2022 Aug 5. doi: 10.1007/s13346-022-01189-4. Online ahead of print. Drug Deliv Transl Res. 2022. PMID: 35930221

8

Magnetic core-shell nanoparticles for drug delivery by nebulization.

Verma NK, Crosbie-Staunton K, Satti A, Gallagher S, Ryan KB, Doody T, McAtamney C, MacLoughlin R, Galvin P, Burke CS, Volkov Y, Gun'ko YK. Verma NK, et al. Among authors: ryan kb. J Nanobiotechnology. 2013 Jan 23;11:1. doi: 10.1186/1477-3155-11-1. J Nanobiotechnology. 2013. PMID: 23343139 Free PMC article.

9

Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery.

Ahern RJ, Hanrahan JP, Tobin JM, Ryan KB, Crean AM. Ahern RJ, et al. Among authors: ryan kb. Eur J Pharm Sci. 2013 Nov 20;50(3-4):400-9. doi: 10.1016/j.ejps.2013.08.026. Epub 2013 Aug 24. Eur J Pharm Sci. 2013. PMID: 23981335

10

Osteointegration, antimicrobial and antibiofilm activity of orthopaedic titanium surfaces coated with silver and strontium-doped hydroxyapatite using a novel blasting process.

O' Sullivan C, O' Neill L, O' Leary ND, O' Gara JP, Crean AM, Ryan KB. O' Sullivan C, et al. Among authors: ryan kb. Drug Deliv Transl Res. 2021 Apr;11(2):702-716. doi: 10.1007/s13346-021-00946-1. Epub 2021 Mar 13. Drug Deliv Transl Res. 2021. PMID: 33713316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results